# US 2004/0204595 A1 · Process for preparing protease inhibitor intermediates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0204595 A1
- Document ID: US20040204595A1
- Status: Published application
- Kind: A1
- Application number: 10/490,186
- Filed: 2004-03-19
- Published: 2004-10-14
- Earliest claimed: 2001-09-20
- Assignees: SmithKline Beecham Corporation
- Inventors: Brian Daniel Doan; Roman D Davis; Thomas Claiborne Lovelace
- Web page: https://patentgrep.com/patent/US20040204595A1

## CPC

- C07D 493/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention includes a method for preparing cyclic alcohols. The method includes a reduction, deprotection, and rearrangement scheme. The present invention further provides a method of preparation of an intermediate useful in the synthesis of compounds that function as inhibitors of the aspartyl protease enzyme of human immunodeficiency virus (HIV).

## Claims

### Claim 1

A method for the preparation of a cyclic alcohol of formula (IV)
27
comprising reducing, deprotecting, and rearranging, in non-aqueous telescoping conditions, an oxetane of formula (II)
28
wherein A is —CH2— and
R1 is
—C(R2)3, where each R2 is independently selected from the group consisting of H, alkyl, and aryl;
—C(O)R3, wherein R3 is selected from the group consisting of alkyl and aryl; or
—Si(R3)3, wherein each R3 is independently as defined above.

### Claim 2 (depends on 1)

The method of claim 1 wherein R1 is —C(R2)3, one R2 is —CH3, one R2 is —CH3, and one R2 is phenyl and the reduction, deprotection, and rearrangement is conducted in situ with palladium on carbon with one of formic acid, ammonium formate, or hydrogen.

### Claim 3 (depends on 2)

The method of claim 2 wherein the in situ reaction agent is palladium on carbon with hydrogen.

### Claim 4 (depends on 3)

The method of claim 3 wherein the catalyst is 10% Pd/C.

### Claim 5 (depends on 2)

The method of claim 2 wherein the the reduction, deprotection, and rearrangement is conducted in situ with a solvent selected from the group consisting of methanol, ethanol, ethyl acetate, dimethoxyethane, and THF.

### Claim 6 (depends on 5)

The method of claim 5 wherein the solvent is THF.

### Claim 7 (depends on 1)

The method of claim 1 wherein R1 is —Si(R3)3, wherein each R3 is C1-8 alkyl.

### Claim 8 (depends on 1)

The method of claim 1 further comprising:
resolving the cyclic alcohol to provide an enantioenriched mixture.

### Claim 9 (depends on 1)

The method of claim 1 further comprising:
resolving the cyclic alcohol to provide an enantiomerically pure cyclic alcohol.

### Claim 10

A method for the preparation of hexahydrofuro[2,3-b]furan-3-ol, comprising:
a) reacting a compound of formula (I) with furan in the presence of light;
29
wherein A is —CH2— or —C(O)—, provided that
when A is —CH2—
R1 is selected from:
—C(R2)3, where each R2 is independently selected from the group consisting of H, alkyl, and aryl;
—C(O)R3, wherein R3 is selected from the group consisting of alkyl and aryl; or
—Si(R3)3, wherein each R3 is independently as defined above; and
when A is —C(O)—,
R1 is selected from alkyl or aryl;
to produce a 2,7-dioxabicyclo[3.2.0]hept-3-ene derivative; and
reducing, deprotecting, and rearranging in non-aqueous telescoping conditions the 2,7-dioxabicyclo[3.2.0]hept-3-ene derivative to produce hexahydrofuro[2,3-b]furan-3-ol.

### Claim 11 (depends on 10)

The method of claim 10 further comprising:
resolving the hexahydrofuro[2,3-b]furan-3-ol.

### Claim 12 (depends on 11)

The method according to claim 11, wherein said resolution further comprises:
i) reacting (3α,3aβ,6aβ)-hexahydrofuro[2,3-b]furan-3-ol with an acylating agent to afford an acyl derivative; and
ii) reacting said acyl derivative with an esterase enzyme to afford (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol.

### Claim 13 (depends on 10)

The method according to claim 10, wherein when R1 is —Si(R3)3, the method further comprises:
cleaving the silyl group.

### Claim 14 (depends on 10)

The method of claim 10 wherein when R1 is —C(O)R3—, the method further comprises a hydride reduction.

### Claim 15 (depends on 14)

The method of claim 14 wherein said hydride reduction comprises using an agent selected from the group consisting of aluminum hydride, di-isobutylaluminum hydride, lithium aluminum hydride, borane, and modified sodium borohydride.
